10:41 AM EST - ProMIS Neurosciences, Inc. : Announced that it has initiated commercialization of its COVID-19 serology assay and has appointed Owen Dempsey to lead the commercialization program. ProMIS Neurosciences, Inc.
shares T.PMN are trading up $0.025 at $0.21.
